Tarsus Pharmaceuticals Inc (TARS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tarsus Pharmaceuticals Inc   (NASDAQ: TARS)


Tarsus Pharmaceuticals Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tarsus Pharmaceuticals Inc's ROI in the second quarter of 2026?
Tarsus Pharmaceuticals Inc recorded a cumulative net loss of $-46 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -10.83%.

Within the Healthcare sector 258 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 1944 to 3124.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 14.11 % 31.08 % 40.6 % 37.63 % 36.08 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 435 438 426 418 483
Return On Investment (TTM) -10.83 % -10.94 % -15.25 % -20.14 % -24.46 %
TARS's Overall Ranking # 3124 # 1944 # 2296 # 3157 #
Seq. Investment Change TTM -2.72 % 1.33 % 8.07 % 7.12 % 11.74 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -46 -48 -66 -81 -92

TARS Company Profile >> Back to TARS Roi Comparisons >> See Annual TARS Return On Investment



Return On Investment TARS's Ranking
Within: No.
Industry # 27
Sector # 259
Overall # 3124

Return On Investment Statistics
High Average Low
156.74 %
-18.49 %
-64.27 %
(Dec 31 2020)   (Dec 31 2023)







Financial Statements
Tarsus Pharmaceuticals Inc's II. Quarter Investments $ 435 Millions TARS's Balance sheet
Tarsus Pharmaceuticals Inc's II. Quarter Income $ -19 Millions Quarterly TARS's Income Statement
TARS's Income by Division See TARS's Income by Division


TARS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 426 296 229 212 167
Y / Y Investment Growth 43.89 % 29.68 % 7.59 % 26.88 % 0.51 %
Net Income in Millions -66 -116 -136 -62 -14
Y / Y Net Income Growth - - - - -
Annual Return On Investment -15.57 % -38.99 % -59.46 % -29.23 % -8.26 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TARS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TARS's Competitors
Subscribers only: Roi for Tarsus Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for TARS's Customers

Other Ratios
TARS's Roa TARS's Inventory Turnover Ratio TARS's Growth Rates TARS's Dividend Statistics
TARS's Profitability Ratios TARS's Asset Turnover Ratio TARS's Dividend Growth
TARS's Roe TARS's Valuation Ratios TARS's Financial Strength Ratios TARS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.